🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06536608
Recruiting Not applicable

The Effect of Oketani Breast Massage on Breastfeeding

NCT06536608 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-11-04
Last updated
2024-11-27

Condition(s) studied

Breast FeedingMassage

Investigational drug(s) / intervention(s)

Massage

Massage: The Oketani Method is based upon practical breastfeeding theory, but is original in its practice. Oketani breast massage improves breastmilk secretion, can prevent and treat problems such as mastitis. In addition, the massage is painless, allowing your body to relax and breathe, something very much appreciated by mothers. The Oketani breast massage consists of massaging and milking the base of the breasts. These delicate glands are massaged as well as protected.

Study summary

This study aims to determine the effects of Oketani breast massage on breastfeeding success, breastfeeding self-efficacy and satisfaction of primiparous mothers.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * To volunteer to participate in the study, * To be over 18 years of age, * To be able to read and write, * To be able to read and understand Turkish, * To have no hearing, speech or visual impairments, * To have received breastfeeding training at a pregnancy school, * To be healthy in the 36th week of primiparous pregnancy. Exclusion Criteria: * Obstacles to communication include having a visual, hearing or perception disorder, * Not being able to read or write, * Having a psychiatric illness, * Being multiparous and having a vaginal birth, * Having a risky pregnancy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cankiri State Hospital Çankırı Turkey (Türkiye) Recruiting

More Saglik Bilimleri Universitesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06536608 on ClinicalTrials.gov ↗ ← All trials in Turkey